AutoantibodiesContraindicationsDeamino Arginine Vasopressin
Dr. Renuka Gera, MD
NPI1033127626PAC ID2567428758
- Publications
- 12
- Clinical trials
- 18
- Industry payments
- $9,940
- Affiliated sites
- 3
- Medical groups
- 3
- Practice address
- 1215 E Michigan Ave, Lansing, MI 48912
- Practice phone
- Call (517) 364-6000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
UM Health-Sparrow Lansing Campus
Lansing, Michigan
Find Dr. Gera's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Renuka Gera is a pediatric hematology and oncology physician in Lansing, Michigan
Dr. Gera practices at UM Health-Sparrow Lansing Campus in Lansing, Michigan.
Dr. Gera's NPI, 1033127626, was assigned on August 3, 2006. Dr. Gera graduated from Gajra Raja Medical College in 1974. Dr. Gera's Michigan license number on file is 4301045225.
NPI and contact details
- NPI
- 1033127626NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2567428758
- NPI enumeration date
- August 3, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (517) 364-6000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 79
- Medical school graduation
- 1974
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Renuka Gera practices at UM Health-Sparrow Lansing Campus in Lansing, Michigan
Dr. Gera's primary practice is UM Health-Sparrow Lansing Campus, at 1215 E Michigan Ave, Lansing, MI 48912 in Ingham County. The practice phone is (517) 364-6000.
- UM Health-Sparrow Lansing Campus1215 E Michigan Ave, Lansing, MI 48912 · Ingham CountyPhone(517) 364-6000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Renuka Gera is affiliated with 4 sites of care and 3 medical groups
Dr. Gera's primary practice is UM Health-Sparrow Lansing Campus in Lansing, Michigan. The medical group on file is University of Michigan Health-Sparrow. Dmand AI also links Dr. Gera to 3 more group practices and clinics and 2 medical groups, each named with a free account.
UM Health-Sparrow Lansing CampusPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Renuka Gera's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gera practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UM Health-Sparrow Lansing Campus | Available with a free account |
| +3 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Gera practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Renuka Gera is one of 86 pediatric hematologys and oncology physicians in Michigan
Pediatric hematology-oncology is Dr. Gera's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Gera is board certified in pediatric hematology-oncology by the American Board of Pediatrics. Dr. Gera has a license on file in Michigan.
Specialties and state licenses
- Pediatric hematology and oncology, MichiganPrimary
Pediatric hematologys and oncology physicians near Dr. Gera
Counts of pediatric hematologys and oncology physicians with a Dmand AI profile, by place and practice. Each opens the list.
86pediatric hematologys and oncology physicians in Michigan
2pediatric hematologys and oncology physicians in Lansing
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Renuka Gera's patients have a median age of 16
Across all payers, Dmand AI patient panel data puts Dr. Gera's median patient age at 16, with 58% women.
Dr. Gera's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 16
Patient panel by sex, all payers
- Women58%
- Men42%
Source: Dmand AI Patient Panel Data
How Dr. Renuka Gera takes part in Medicare
Dr. Gera accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
Dr. Renuka Gera has 12 publications on record
Dmand AI links 12 papers to Dr. Gera, published from 2012 to 2016. The most frequent topics are Hemophilia A, Hepatitis C and HIV Infections. Dr. Gera has published most often in J Pediatr Hematol Oncol. Dr. Gera's most frequent co-authors are Priya S. Kishnani, Joyce A. Kobori, MD and Suhrad Banugaria, MD.
Papers12
Years published2012 to 2016
Topics Dr. Gera writes about most
- Hemophilia A
- Hepatitis C
- HIV Infections
Dr. Gera's most frequent co-authors
- Priya S. Kishnani3 shared papers
- Joyce A. Kobori, MD3 shared papers
- Suhrad Banugaria, MD1 shared paper
Recent publications by Dr. Gera
J Pediatr Hematol Oncol
Anemia, Sickle CellArnold-Chiari MalformationDiagnosis, Differential
See who Dr. Gera researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Gera works with, so you can find a warm path to the right pediatric hematologys and oncology physicians.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Renuka Gera has worked on 18 clinical trials
Dmand AI links Dr. Gera to 18 clinical trials, 9 of them phase 3 studies. 13 are still active or recruiting. Conditions studied include Burkitt Lymphoma, Medulloblastoma and Precursor Cell Lymphoblastic Leukemia-Lymphoma. National Cancer Institute (NCI) sponsors the most, 10.
Clinical trials with Dr. Gera by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 9Phase 3: 9 trials
- NonePhase 4: no trials
Conditions in Dr. Gera's trials
- Burkitt Lymphoma
- Medulloblastoma
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Epstein-Barr Virus Infections
- Angiolipoma
Investigators on the most trials with Dr. Gera
- Wendy L. Woods-Swafford, MD16 shared trials
- Mark Anthony Ranalli, MD15 shared trials
- Judy Linn Felgenhauer, MD14 shared trials
Recent clinical trials with Dr. Gera
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) (opens in a new tab)
Active, not recruitingPhase 3
Burkitt LymphomaEpstein-Barr Virus InfectionsBlinatumomabAsparaginaseCyclophosphamide
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma (opens in a new tab)
Active, not recruitingPhase 2
MedulloblastomaNeuroectodermal Tumors, PrimitiveRadiation TherapyCisplatinCyclophosphamide
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma (opens in a new tab)
Active, not recruitingPhase 3
Rhabdomyosarcoma, EmbryonalRhabdomyosarcoma, AlveolarTemsirolimusCyclophosphamideDactinomycin
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Brentuximab VedotinBleomycin SulfateCyclophosphamide
Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma (opens in a new tab)
Active, not recruitingPhase 3
Precursor T-Cell Lymphoblastic Leukemia-LymphomaPrecursor Cell Lymphoblastic Leukemia-LymphomaBortezomibCyclophosphamideCytarabine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Renuka Gera received $9,940 in industry payments from 2016 to 2025
CMS Open Payments shows 35 general payments to Dr. Gera from 15 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 34% of the total. CSL Behring paid the most, $4,965. It also lists 8 research payments totaling $1,402 in 2016.
General payments to Dr. Gera by program year, 2016 to 2025
General payments to Dr. Gera by kind, 2016 to 2025
$9.9Kin total
- Honoraria$3,38034%
- Consulting fees$2,50025%
- Travel and lodging$2,33423%
- Food and beverage$1,64517%
- Education$811%
Companies that paid Dr. Gera the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Renuka Gera graduated from Gajra Raja Medical College
Dr. Gera graduated from Gajra Raja Medical College in 1974.
- Medical school
- Board certified in pediatric hematology-oncology
- Board certified in pediatrics
Source: Dmand AI Professional Profile Data
Dr. Renuka Gera accepts plans from 15 insurance carriers
Dr. Gera is in network with 15 carriers, including Aetna, Elevance and Health Alliance Plan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Aetna
- Elevance
- Health Alliance Plan
- Blue Cross Blue Shield of Michigan
- Priority Health
- United Healthcare
- Blue Cross Blue Shield of Massachusetts
- HCSC
- +7 more carriersWith a free account
Plan types Dr. Gera accepts, by number of carriers
- Medicare10
- PPO9
- HMO8
- POS7
- EPO4
- Medicaid1
Source: Dmand AI Insurance Network Data
Sources for Dr. Renuka Gera's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Renuka Gera
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Renuka Gera's NPI number?
Dr. Renuka Gera's NPI number is 1033127626. It was assigned on August 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Renuka Gera?
Dr. Renuka Gera is a pediatric hematology and oncology physician in Lansing, Michigan. The primary specialty in the NPI Registry is Pediatric Hematology & Oncology Physician (taxonomy code 2080P0207X).
Where does Dr. Renuka Gera practice?
Dr. Gera practices at 1215 E Michigan Ave, Lansing, MI 48912. Dr. Gera's primary practice is UM Health-Sparrow Lansing Campus in Lansing, Michigan. Dmand AI also links Dr. Gera to 3 group practices and clinics and 2 medical groups.
What is Dr. Renuka Gera's office phone number?
The practice phone on file for Dr. Gera is (517) 364-6000.
What is Dr. Renuka Gera's medical license number?
Dr. Gera's Michigan license number on file is 4301045225.
What medical group is Dr. Renuka Gera part of?
Dr. Gera is linked to University of Michigan Health-Sparrow. Dmand AI links Dr. Gera to 2 more medical groups.
Does Dr. Renuka Gera accept Medicare?
Yes. CMS lists Dr. Gera as accepting Medicare assignment.
Is Dr. Renuka Gera board certified?
Yes. Dr. Gera is board certified in pediatric hematology-oncology by the American Board of Pediatrics.
Where did Dr. Renuka Gera go to medical school?
Dr. Gera graduated from Gajra Raja Medical College in 1974.
Has Dr. Renuka Gera received payments from drug or device companies?
CMS Open Payments shows $9,940 in general payments to Dr. Gera from 15 companies from 2016 to 2025. The largest total came from CSL Behring.
Show 4 more questionsShow fewer questions
How long has Dr. Renuka Gera been practicing?
Dr. Gera graduated from medical school in 1974, 52 years ago.
Does Dr. Renuka Gera do research?
Dmand AI links 12 publications to Dr. Gera, published from 2012 to 2016. Dr. Gera has worked on 18 clinical trials.
Who does Dr. Renuka Gera publish with?
Dr. Gera's most frequent co-authors are Priya S. Kishnani (3 shared papers), Joyce A. Kobori, MD (3 shared papers) and Suhrad Banugaria, MD (1 shared paper).
What insurance does Dr. Renuka Gera accept?
Dr. Gera is in network with 15 carriers, including Aetna, Elevance and Health Alliance Plan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to pediatric hematology-oncology practices?
See pediatric hematologys and oncology physicians in Michigan by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card